Malvern Instruments to Acquire MicroCal
Malvern Instruments will acquire the MicroCal business from GE Healthcare Life Sciences.
Malvern Instruments has entered into an agreement with GE Healthcare Life Sciences to acquire MicroCal, GE’s microcalorimetry business. The acquisition, which is subject to regulatory approvals, is expected to complete in the third quarter of 2014. Financial terms were not disclosed.
MicroCal differential scanning calorimeters and isothermal titration calorimeters are used in areas from basic research to the discovery and development of small molecules, biotherapeutics, and vaccines. MicroCal will be located in Northampton, MA.
Source: Malvern Instruments
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
